Concepedia

Yongqiang Xiao

YX

Statistics

Publications

3

Citations

87

H-Index

3

Active since

2022

Affiliations

Nanchang University(Current)

First Affiliated Hospital of Nanchang University

Yongqiang Xiao is an author at Nanchang University specializing in medicine, cancer immunotherapy, and hepatocellular carcinoma treatment.

ORCID

Publications per year

2022–2023

3

Publications

3

Hepatic arterial infusion chemotherapy combined with PD-1 inhibitors and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: A tertiary medical center experience

Laihui Luo, Yongqiang Xiao, Guoqing Zhu et al. · Frontiers in Oncology · 2022 · 39 citations · Full text

, , +15

Hepatectomy After Conversion Therapy for Initially Unresectable HCC: What is the Difference?

Laihui Luo, Yongzhu He, Guoqing Zhu et al. · Journal of Hepatocellular Carcinoma · 2022 · 31 citations · Full text

, , +11

Pretreatment Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Patients with Unresectable Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab

Yongqiang Xiao, Guoqing Zhu, Jin Xie et al. · Journal of Hepatocellular Carcinoma · 2023 · 17 citations · Full text

, , +13

1–3 of 3